Friday, August 1, 2025

AU Small Finance Bank shares downgraded by Kotak; 15% downside expected

Date:

Shares of AU Small Finance Bank Ltd. are in focus on Monday, July 14, after brokerage firm Kotak Institutional Equities downgraded its rating on the stock but increased its target price by nearly 8%.The brokerage has downgraded its rating on the stock to “sell” from “add” and has raised its target price from ₹650 per share to ₹700 apiece, implying a downside of nearly 15% from its previous closing price on Friday.
It said that while challenges in unsecured businesses have hurt the lender’s profitability in the financial year 2025, those issues are expected to get sorted in the ongoing fiscal.
If macro environment turns favourable, AU Small Finance Bank can deliver healthy business growth ahead of peer banks, the brokerage said.However, the recent stock price rally has made risk-reward proposition less attractive, it added.

Kotak Institutional Equities said it prefers to play cyclical recovery trade through other stocks where valuation is relatively inexpensive.

Last week, the lender said it partnered with the Life Insurance Corporation of India (LIC) to distribute LIC’s life insurance products across its network. The collaboration aims to improve access to life insurance among underserved and unserved populations across India.AU Small Finance Bank reported a 10.7% sequential gain in its total deposits in the fourth quarter to ₹1.24 lakh crore from ₹1.12 lakh crore. The same was 27.2% more than the previous year’s ₹97,704 crore.

The lender’s current and savings account (CASA) deposits increased 5.4% to ₹36,250 crore from the December quarter’s ₹34,492 crore. It was also up 15.2% 4 up from the previous year’s ₹31,456 crore.

The CASA ratio came in at 29.2% compared to the previous quarter’s 30.6%. It was 32.2% in the year-ago period.

Of the 34 analysts that have coverage on the stock, 23 have a “buy” rating, six have a “hold” rating and five have a “sell” rating.

AU Small Finance Bank ended the previous session 0.75% lower. The stock has gained 44.57% this year, so far.

Also Read: Glenmark Pharma’s Indore unit gets USFDA warning letter; Stock in F&O ban

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

New India Assurance Q1 premium up 13% to ₹13,334 crore; profit rises despite Air India impact

State-run New India Assurance Company Ltd on Tuesday (July...

How To Negotiate With Someone Like Trump – And Win

Trump’s hard-bargaining tactics are already used in the business...

ITC Q1 Results: Net profit remains flat at ₹4,912 crore; revenue up 15%

विविधतापूर्ण समूह आईटीसी लिमिटेड ने अपने जून तिमाही (Q1FY26)...

Trump calls on Fed board to overrule Powell on interest rates

US President Donald Trump on Friday, August 1, urged...